Healthcare providers often prescribe
Colazal® (
balsalazide disodium) for the treatment of
ulcerative colitis, a type of inflammatory bowel disease (IBD). Colazal is approved for mild-to-moderately active cases of the disease, and can be used in people who are at least five years old.
Clinical research has shown the product's effectiveness in treating ulcerative colitis. For example, in previous studies, up to 55 percent of people taking Colazal had less blood in the stool after eight weeks, compared to just 35 percent of those not taking it. The drug also helped people have fewer trips to the toilet.
(To learn more about this ulcerative colitis drug, click Colazal Uses. This article also describes an "off-label" use of this product and talks in more detail about the treatment options available for people with this disease.)
HealthSavvy Sign In
|